Join us for the Updates in Primary Immunodeficiency 2026 CME symposium.
This course provides an educational forum for faculty to deliver in-depth reviews of common and rare inborn errors of immunity (IEI), a group of more than 600 complex, chronic disorders.
After completing this educational activity, participants will be able to do the following:
- Provide an update on common variable immunodeficiency syndrome and research on IgE levels in immunodeficiency.
- Describe advances in specific antibody deficiency and utilize vaccine testing guidelines.
- Summarize recent advancements in identifying and treating hematologic complications including chronic neutropenia and immune thrombocytopenia.
- Discuss the increased cancer risks in immunocompromised patients and their implications for cancer screening.
- Review the clinical presentation, pathogenesis, diagnosis, and treatment of various immune disorders caused by cellular defects.
- Recognize, assess, and diagnose common symptoms seen in immunocompromised patients to help improve patient outcomes given earlier diagnosis.
- Define uses of artificial intelligence to improve and individualize therapy in patients with immune dysfunction.
- Critically appraise innovations in immunoglobulin replacement therapy, gene therapy, and stem cell transplantation in the treatment of immunodeficiency syndromes.
- Summarize the efficacy, side effects, and clinical implications of therapeutic options in management strategies for patients with complex immunodeficiency diseases.
Who Should Attend?
This course is designed for health care professionals, including physicians, physician assistants, nurse practitioners, fellows, and residents, with an interest in allergy, immunology, rheumatology, hematology and beyond.
Endorsed By:
